BICO Group AB

Equities

BICO

SE0013647385

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:38 2024-04-26 am EDT			5-day change	1st Jan Change
45.6 ^SEK	+2.89%		+3.07%	-19.94%

Apr. 18	BICO Group AB Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024	CI
Apr. 16	BICO Group AB Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors	CI

BICO Group AB Provides Preliminary Unaudited Financial Guidance for the Fourth Quarter and Full Year of 2023

February 14, 2024 at 01:02 pm EST

BICO Group AB (publ) provided preliminary unaudited financial guidance for the fourth quarter and full year of 2023. The net sales for fourth quarter is expected to amount to SEK 636.6 million.

Net sales for fiscal year 2023 is expected to amount to SEK 2,249.9 million.

Latest news about BICO Group AB

BICO Group AB Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024	Apr. 18	CI
BICO Group AB Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors	Apr. 16	CI
BICO Group AB Announces Management Resignations	Mar. 15	CI
Transcript : BICO Group AB, Q4 2023 Earnings Call, Feb 20, 2024	Feb. 20
BICO Group AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
BICO Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
BICO Group AB Announces Goodwill Impairment for the Fourth Quarter of 2023	Feb. 14	CI
BICO Group AB Provides Preliminary Unaudited Financial Guidance for the Fourth Quarter and Full Year of 2023	Feb. 14	CI
BICO Group AB Appoints Catharina Nordlund as Global Head of HR	Jan. 25	CI
Beos Light Industrial Germany 1 Fund managed by BEOS AG completed the acquisition of property on Wagner-Régeny-Straße 15 from BICO Group AB (OM:BICO) for ?21 million.	Nov. 29	CI
BICO's New CEO/President to Assume Roles Nov. 20	Nov. 14	MT
Transcript : BICO Group AB, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
BICO Group AB Announces the Appointment of Nomination Committee	Nov. 14	CI
BICO Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
BICO Group AB Appoints Maria Forss Assumes Office as President	Nov. 13	CI
BICO Group AB Appoints Maria Forss as CEO, Effective from on November 20, 2023	Nov. 13	CI
Bico Group Divests Ginolis in EUR1 Management Buyout Deal	Nov. 13	MT
Kauko Väinämö acquired Ginolis Ltd from BICO Group AB (OM:BICO) for ?1.	Nov. 12	CI
Transcript : BICO Group AB - Special Call	23-08-22
Transcript : BICO Group AB, Q2 2023 Earnings Call, Aug 22, 2023	23-08-22
BICO Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
BICO Group's President, CEO Resigns; Vitrolife Exec Named Successor	23-08-22	MT
Maria Forss has acquired 0.028 million shares in BICO Group AB.	23-08-21	CI
BICO Group AB Resolves to Write-Down Goodwill for the Second Quarter of 2023	23-08-21	CI
BICO Group AB Announces Chief Executive Officer Changes	23-08-21	CI

Chart BICO Group AB

Duration

Period

More charts

Company Profile

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Companyâs operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for BICO Group AB

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

45.6 SEK

Average target price

132.5 SEK

Spread / Average Target

+190.57%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BICO GROUP AB	-19.94%	294M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology